Indian endocrinologists, however, say the risk appears small and patients should not panic, while stressing on eye examinations if symptoms develop
FDA flags rare vision-loss risk with GLP-1 drugs; doctors say patients need not panic
EXECUTIVE SUMMARY
Indian endocrinologists, however, say the risk appears small and patients should not panic, while stressing on eye examinations if symptoms develop
Key Takeaways
- FDA flags rare vision-loss risk with GLP-1 drugs; doctors say patients need not panic.
Read Complete Original Article
Published originally on The Hindu Business Line
